197 related articles for article (PubMed ID: 38450224)
1. Effects of speech rate modifications on phonatory acoustic outcomes in Parkinson's disease.
Knowles T; Adams SG; Jog M
Front Hum Neurosci; 2024; 18():1331816. PubMed ID: 38450224
[TBL] [Abstract][Full Text] [Related]
2. Variation in Speech Intelligibility Ratings as a Function of Speech Rate Modification in Parkinson's Disease.
Knowles T; Adams SG; Jog M
J Speech Lang Hear Res; 2021 Jun; 64(6):1773-1793. PubMed ID: 33950711
[TBL] [Abstract][Full Text] [Related]
3. Acoustic characteristics in relation to intelligibility reduction in noise for speakers with Parkinson's disease.
Chiu Y; Neel A; Loux T
Clin Linguist Phon; 2021 Mar; 35(3):222-236. PubMed ID: 32539544
[TBL] [Abstract][Full Text] [Related]
4. Speech Rate Mediated Vowel and Stop Voicing Distinctiveness in Parkinson's Disease.
Knowles T; Adams SG; Jog M
J Speech Lang Hear Res; 2021 Nov; 64(11):4096-4123. PubMed ID: 34582276
[TBL] [Abstract][Full Text] [Related]
5. An exploratory model of speech intelligibility for healthy aging based on phonatory and articulatory measures.
Kuruvilla-Dugdale M; Dietrich M; McKinley JD; Deroche C
J Commun Disord; 2020; 87():105995. PubMed ID: 32531515
[TBL] [Abstract][Full Text] [Related]
6. Articulation Features of Parkinson's Disease Patients with Subthalamic Nucleus Deep Brain Stimulation.
Tanaka Y; Tsuboi T; Watanabe H; Kajita Y; Nakatsubo D; Fujimoto Y; Ohdake R; Ito M; Atsuta N; Yamamoto M; Wakabayashi T; Katsuno M; Sobue G
J Parkinsons Dis; 2016 Oct; 6(4):811-819. PubMed ID: 27662325
[TBL] [Abstract][Full Text] [Related]
7. Vocalic transitions as markers of speech acoustic changes with STN-DBS in Parkinson's Disease.
Martel-Sauvageau V; Tjaden K
J Commun Disord; 2017 Nov; 70():1-11. PubMed ID: 29032347
[TBL] [Abstract][Full Text] [Related]
8. Results of a Randomized Clinical Trial of Speech After Early Neurostimulation in Parkinson's Disease.
Pinto S; Nebel A; Rau J; Espesser R; Maillochon P; Niebuhr O; Krack P; Witjas T; Ghio A; Cuartero MC; Timmermann L; Schnitzler A; Hesekamp H; Meier N; Müllner J; Hälbig TD; Möller B; Paschen S; Paschen L; Volkmann J; Barbe MT; Fink GR; Becker J; Reker P; Kühn AA; Schneider GH; Fraix V; Seigneuret E; Kistner A; Rascol O; Brefel-Courbon C; Ory-Magne F; Hartmann CJ; Wojtecki L; Fradet A; Maltête D; Damier P; Le Dily S; Sixel-Döring F; Benecke P; Weiss D; Wächter T; Pinsker MO; Régis J; Thobois S; Polo G; Houeto JL; Hartmann A; Knudsen K; Vidailhet M; Schüpbach M; Deuschl G;
Mov Disord; 2023 Feb; 38(2):212-222. PubMed ID: 36461899
[TBL] [Abstract][Full Text] [Related]
9. Speech Intelligibility During Clinical and Low Frequency.
Sidtis JJ; Sidtis DVL; Ramdhani R; Tagliati M
Brain Sci; 2020 Jan; 10(1):. PubMed ID: 31906549
[No Abstract] [Full Text] [Related]
10. Deep Brain Stimulation of the Subthalamic Nucleus Parameter Optimization for Vowel Acoustics and Speech Intelligibility in Parkinson's Disease.
Knowles T; Adams S; Abeyesekera A; Mancinelli C; Gilmore G; Jog M
J Speech Lang Hear Res; 2018 Mar; 61(3):510-524. PubMed ID: 29471373
[TBL] [Abstract][Full Text] [Related]
11. Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson's disease.
Klostermann F; Ehlen F; Vesper J; Nubel K; Gross M; Marzinzik F; Curio G; Sappok T
J Neurol Neurosurg Psychiatry; 2008 May; 79(5):522-9. PubMed ID: 17766427
[TBL] [Abstract][Full Text] [Related]
12. Dysarthria and Speech Intelligibility Following Parkinson's Disease Globus Pallidus Internus Deep Brain Stimulation.
Chiu SY; Tsuboi T; Hegland KW; Herndon NE; Shukla AW; Patterson A; Almeida L; Foote KD; Okun MS; Ramirez-Zamora A
J Parkinsons Dis; 2020; 10(4):1493-1502. PubMed ID: 32955467
[TBL] [Abstract][Full Text] [Related]
13. Dysphonia and Dysarthria in People With Parkinson's Disease After Subthalamic Nucleus Deep Brain Stimulation: Effect of Frequency Modulation.
Morello ANDC; Beber BC; Fagundes VC; Cielo CA; Rieder CRM
J Voice; 2020 May; 34(3):477-484. PubMed ID: 30454944
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Speech Change After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease Patients: A 2-Year Prospective Study.
Tanaka Y; Tsuboi T; Watanabe H; Nakatsubo D; Maesawa S; Kato S; Kajita Y; Sato M; Oodake R; Hattori M; Yamamoto M; Wakabayashi T; Katsuno M; Sobue G
J Parkinsons Dis; 2020; 10(1):131-140. PubMed ID: 31884493
[TBL] [Abstract][Full Text] [Related]
15. Tongue- and Jaw-Specific Articulatory Underpinnings of Reduced and Enhanced Acoustic Vowel Contrast in Talkers With Parkinson's Disease.
Mefferd AS; Dietrich MS
J Speech Lang Hear Res; 2019 Jul; 62(7):2118-2132. PubMed ID: 31306611
[TBL] [Abstract][Full Text] [Related]
16. Anterior Sensorimotor Subthalamic Nucleus Stimulation Is Associated With Improved Voice Function.
Jorge A; Dastolfo-Hromack C; Lipski WJ; Kratter IH; Smith LJ; Gartner-Schmidt JL; Richardson RM
Neurosurgery; 2020 Sep; 87(4):788-795. PubMed ID: 32199026
[TBL] [Abstract][Full Text] [Related]
17. Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulation.
Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Yoneyama N; Hara K; Nakamura R; Watanabe H; Senda J; Atsuta N; Ito M; Hirayama M; Yamamoto M; Fujimoto Y; Kajita Y; Wakabayashi T; Sobue G
J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):856-64. PubMed ID: 25280914
[TBL] [Abstract][Full Text] [Related]
18. Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria?
Fabbri M; Zibetti M; Ferrero G; Accornero A; Guimaraes I; Rizzone MG; Romagnolo A; Ferreira JJ; Lopiano L
Parkinsonism Relat Disord; 2019 Jul; 64():242-248. PubMed ID: 31060986
[TBL] [Abstract][Full Text] [Related]
19. Subthalamic nucleus deep brain stimulation changes velopharyngeal control in Parkinson's disease.
Hammer MJ; Barlow SM; Lyons KE; Pahwa R
J Commun Disord; 2011; 44(1):37-48. PubMed ID: 20708741
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal study of speech and dual-task performance in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation.
Catalano Chiuvé S; Fournet M; Wegrzyk J; Assal F; Burkhard PR; Laganaro M
Parkinsonism Relat Disord; 2022 Apr; 97():75-78. PubMed ID: 35349893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
